WO2004076406A3 - Losartan potassium polymorphs and process for the preparation thereof - Google Patents
Losartan potassium polymorphs and process for the preparation thereof Download PDFInfo
- Publication number
- WO2004076406A3 WO2004076406A3 PCT/EP2004/001717 EP2004001717W WO2004076406A3 WO 2004076406 A3 WO2004076406 A3 WO 2004076406A3 EP 2004001717 W EP2004001717 W EP 2004001717W WO 2004076406 A3 WO2004076406 A3 WO 2004076406A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- losartan potassium
- polymorphs
- preparation
- losartan
- potassium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Losartan potassium polymorphs, identified as Losartan potassium crystalline hydrate, Losartan potassium amorphous and Losartan potassium modification crystalline III, a process for their preparation, pharmaceutical compositions containing them and their use in therapy.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2003A000328 | 2003-02-25 | ||
IT000328A ITMI20030328A1 (en) | 2003-02-25 | 2003-02-25 | POLYMORPHS OF LOSARTAN POTASSIUM AND PROCEDURE FOR THEIR PREPARATION. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004076406A2 WO2004076406A2 (en) | 2004-09-10 |
WO2004076406A3 true WO2004076406A3 (en) | 2005-01-13 |
Family
ID=32923033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/001717 WO2004076406A2 (en) | 2003-02-25 | 2004-02-20 | Losartan potassium polymorphs and process for the preparation thereof |
Country Status (2)
Country | Link |
---|---|
IT (1) | ITMI20030328A1 (en) |
WO (1) | WO2004076406A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060160871A1 (en) * | 2004-12-07 | 2006-07-20 | Nektar Therapeutics | Stable non-crystalline formulation comprising losartan |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
US5608075A (en) * | 1993-12-23 | 1997-03-04 | Merck & Co., Inc. | Polymorphs of losartan and the process for the preparation of form II of losartan |
WO2002094816A1 (en) * | 2001-05-18 | 2002-11-28 | Aurobindo Pharma Limited | Process for the crystallization of losartan potassium |
WO2003048135A1 (en) * | 2001-11-14 | 2003-06-12 | Teva Pharmaceutical Industries Ltd. | Amorphous and crystalline forms of losartan potassium and process for their preparation |
-
2003
- 2003-02-25 IT IT000328A patent/ITMI20030328A1/en unknown
-
2004
- 2004-02-20 WO PCT/EP2004/001717 patent/WO2004076406A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
US5608075A (en) * | 1993-12-23 | 1997-03-04 | Merck & Co., Inc. | Polymorphs of losartan and the process for the preparation of form II of losartan |
WO2002094816A1 (en) * | 2001-05-18 | 2002-11-28 | Aurobindo Pharma Limited | Process for the crystallization of losartan potassium |
WO2003048135A1 (en) * | 2001-11-14 | 2003-06-12 | Teva Pharmaceutical Industries Ltd. | Amorphous and crystalline forms of losartan potassium and process for their preparation |
Also Published As
Publication number | Publication date |
---|---|
ITMI20030328A1 (en) | 2004-08-26 |
WO2004076406A2 (en) | 2004-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1475228B8 (en) | Coextruded, heat-sealable and peelable polyesterfilm, process for its production and its use | |
HUS1400056I1 (en) | Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof | |
PL378065A1 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
IL183568A (en) | Process for preparing 7,8-dihydro-5h-pteridin-6-one derivatives | |
HUE037069T2 (en) | Process for the preparation of highly pure 2,4'-methylenediphenyldiisocyanate | |
AU2003243354A1 (en) | Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods | |
IL181012A0 (en) | Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments | |
HRP20050328A2 (en) | Process for the preparation of (s,s)-cis-2-benzhyd | |
EP1946668B8 (en) | Interlock tool, bag making use thereof and process for producing them | |
WO2007000325A3 (en) | Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-on- compounds and the use thereof for producing drugs | |
ZA200309709B (en) | Solid crystalline IM-9, and a process for its preparation. | |
IL164442A0 (en) | Benzoxazinone-derived compounds, their preparationand use as medicaments | |
IL162316A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t | |
AU2003271185A1 (en) | Imidazopyridine derivative, process for producing the same, and use | |
PL394600A1 (en) | Vinylazocycloalkanyl compound, process for the preparation thereof, its use and pharmaceutical composition | |
HK1108580A1 (en) | A process for the preparation of [1,4,5]-oxadiazepine derivatives | |
HK1086008A1 (en) | Process for preparing substituted 5-amino-pyrazolo-Ä4,3-eÜ-1,2,4-triazoloÄ1,5-cÜpyrimidines | |
HUP0401522A2 (en) | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation | |
AU2003245040A1 (en) | Process for purifying pentafluoroethane, process for producing the same, and use thereof | |
IL190596A0 (en) | 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
HK1100946A1 (en) | 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | |
AU2003253010A1 (en) | Novel amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a, process for preparing the same, and use thereof | |
WO2004076406A3 (en) | Losartan potassium polymorphs and process for the preparation thereof | |
ZA200702070B (en) | Process for preparing substituted 8-azablcyclo[3.2.1] octan-3-ols | |
ZA200501010B (en) | BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |